ACRO Biomedical Co. Ltd. announced that on January 30, 2017, Gordon Lett, who was president, chief executive officer, chief financial officer and a director of the company, and Marian Prosser, who was secretary and a director, resigned as directors and officers of the company. Mr. Lett and Ms. Prosser were the company's only officers and directors.

Mr. Lett's resignation as a director was effective upon the election by the company's stockholders of a successor director. On January 30, 2017, Mr. Chu, as sole director, executed an action in writing appointing himself as chief executive officer, president, chief financial officer and secretary. Mr. Chu does not have an employment agreement with the company.

Mr. Chu, age 63, has served as the chairman of Mucho Biotech Co. Ltd., Mucho Furich Co. Ltd., and Mucho Biomedical Co.

Ltd. Mr. Chu has more than ten years of experience in the biotech industry with a focus on initiating the integration of cordyceps technology development, which includes cordyceps strains management, cordyceps cultivation, food processing and health products development.